Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added. The label for Intervention/Treatment was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page now shows an updated list of study locations with new sites in Indianapolis, IN (Indiana University) and Rome, Italy, and a reduced total of 43 locations.SummaryDifference0.8%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website version is updated from v3.5.3 to v3.5.4, indicating an under-the-hood update to the platform. No study text or data were changed on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedA new citation has been added to Publications for an immunotherapy article by Davis et al., with full bibliographic details. This adds additional reference material for readers.SummaryDifference0.0%

- Check44 days agoChange DetectedThe study page text did not change; the content described in the provided page context remains the same, including the study overview, eligibility criteria, and listed locations.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s displayed interface revision was updated from v3.5.2 to v3.5.3, indicating a non-content system/version change rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.